Cargando…
Bridging the Gap between Gut Microbiota and Alzheimer’s Disease: A Metaproteomic Approach for Biomarker Discovery in Transgenic Mice
Alzheimer’s Disease (AD) is a progressively debilitating form of dementia that affects millions of individuals worldwide. Although a vast amount of research has investigated the complex interplay between gut microbiota and neurodegeneration, the metaproteomic effects of microbiota on AD pathogenesis...
Autores principales: | Ayan, Esra, DeMirci, Hasan, Serdar, Muhittin Abdulkadir, Palermo, Francesca, Baykal, Ahmet Tarık |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454110/ https://www.ncbi.nlm.nih.gov/pubmed/37629000 http://dx.doi.org/10.3390/ijms241612819 |
Ejemplares similares
-
Neonatal Neurodegeneration in Alzheimer’s Disease Transgenic Mouse Model
por: Mazi, Aise Rumeysa, et al.
Publicado: (2018) -
Metaproteomics—An Advantageous Option in Studies of Host-Microbiota Interaction
por: Karaduta, Oleg, et al.
Publicado: (2021) -
Williams–Beuren syndrome shapes the gut microbiota metaproteome
por: Marzano, Valeria, et al.
Publicado: (2023) -
Metaproteomics as a Complementary Approach to Gut Microbiota in Health and Disease
por: Petriz, Bernardo A., et al.
Publicado: (2017) -
Metaproteomic analysis of human gut microbiota: where are we heading?
por: Lee, Pey Yee, et al.
Publicado: (2017)